Mechanistically, DB-mediated anti-colon cancer activities was associated with the downregulation of stem/oncogenic markers, including β-catenin, c-Myc, and mTOR-associated molecules, while there was upregulation in a tumor suppressor, miR-214. This evidence concerns the gene MTOR and colonic neoplasm.